Popis: |
The chapter describes value creation and valuation under structural uncertainty in the healthcare and pharma industries. These risks and uncertainties can significantly influence organizational performance, value creation and long-term sustainability. The discussion continues by comparing traditional valuation concepts used in finance with the requirements posed by the current situation of healthcare business. In particular, patent valuation is a critical business issue, and the value of pharma patents and licensing deals has risen markedly in recent years. Existing evaluation approaches do not consider a patent’s life cycle, an important and unique characteristic of pharma and biotech patents. For this reason, the inherent uncertainty in a patent’s value is modelled as a stochastic process. |